Evaluation of the thrombolytic potential of Punica granatum by in vitro in vivo and in silico approaches
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Thrombosis is a critical event in the arterial diseases associated with myocardial infarction and stroke Thrombolytic drugs like tissue plasminogen activator tPA urokinase and
newlinestreptokinase play a crucial role in the management of patients with thrombosis To combat the shortcomings of the available thrombolytic drugs a quest for plant based thrombolytics is the
newlineneed of the hour The aril and rind of Punica granatum were explored for the thrombolytic potency in in vitro in vivo and in silico experiments in the present study The findings revealed
newlinethat the present study might have important implications in cardiovascular health in developing countries where cheap and effective medicines are the need of the hour This investigation can
newlinehelp in developing cost effective novel thrombolytic agents from common plant sources which are advantageous over synthetic drugs Pomegranate that is rich in antioxidants possesses good
newlinethrombolytic property Hence it could be used effectively in thrombolytic therapies where the oxidative stress is increased during ischemia and reperfusion Major objectives The present study was formulated with the following objectives To screen diverse plant based sources for thrombolytic activity
newlineTo evaluate the antioxidant potential of the selected plant source
newlineTo isolate the principle compound responsible for thrombolysis and to determine the efficiency in vitro To assess the in vivo clot lysing efficacy of the selected extracts in rats To analyze the interaction of active compounds present in the sample with thrombolytic targets in silico